LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.52 | 84.90 | 4072 | 9214 | 0.4419 | 0.7725 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.52 | 84.90 | 3722 | 9214 | 0.4039 | 0.7491 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.52 | 84.90 | 3847 | 9214 | 0.4175 | 0.7576 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.22 | 84.90 | 3866 | 9343 | 0.4138 | 0.7560 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.22 | 84.90 | 4212 | 9343 | 0.4508 | 0.7783 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.22 | 84.90 | 3839 | 9343 | 0.4109 | 0.7542 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 74.22 | 84.90 | 3962 | 9343 | 0.4240 | 0.7624 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.93 | 84.90 | 4129 | 8970 | 0.4603 | 0.7820 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.93 | 84.90 | 4369 | 8970 | 0.4870 | 0.7970 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.93 | 84.90 | 3908 | 8970 | 0.4356 | 0.7675 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.93 | 84.90 | 4086 | 8970 | 0.4555 | 0.7792 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 77.64 | 84.90 | 4330 | 9245 | 0.4683 | 0.7879 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 77.64 | 84.90 | 4576 | 9245 | 0.4949 | 0.8026 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 77.64 | 84.90 | 4053 | 9245 | 0.4384 | 0.7705 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 77.64 | 84.90 | 4218 | 9245 | 0.4562 | 0.7810 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 79.34 | 84.90 | 4137 | 9051 | 0.4571 | 0.7805 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 79.34 | 84.90 | 4669 | 9051 | 0.5158 | 0.8128 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 79.34 | 84.90 | 4194 | 9051 | 0.4634 | 0.7842 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 79.34 | 84.90 | 4373 | 9051 | 0.4831 | 0.7953 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.05 | 84.90 | 4278 | 8863 | 0.4826 | 0.7941 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.05 | 84.90 | 4785 | 8863 | 0.5398 | 0.8243 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.05 | 84.90 | 4272 | 8863 | 0.4820 | 0.7937 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 81.05 | 84.90 | 4480 | 8863 | 0.5054 | 0.8065 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.75 | 84.90 | 4372 | 8621 | 0.5071 | 0.8063 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.75 | 84.90 | 4981 | 8621 | 0.5777 | 0.8420 | MN20160318_Q02 | L07 |